Every year, millions of people suffer from debilitating diseases of the central nervous system (CNS) that traditional pharmaceutical and biotechnology products cannot repair. Q Therapeutics is working to address this medical challenge with new cellular products intended to restore normal function in damaged nervous system tissues. Our first product, Q-Cells™, is designed to replace myelin on injured neurons.  Our initial focus includes testing in transverse myelitis and use of Q-Cells as a unique drug screening tool to identify follow-on pharmaceutical products.